Consolidated Statements Of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 536,673	$ 698,029
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	262,883	224,381
Net loss of equity method investments, inclusive of distributions	5,268	3,184
Loss on early extinguishment of debt attributable to unamortized discount	1,489	7,948
Loss on sale of assets	556	0
Deferred income taxes	(2,169)	47,053
Equity based compensation expense	20,728	25,239
Change in fair value - derivative instruments	(12,199)	(39,745)
(Increase) decrease in current assets:
Accounts receivable	8,530	(110,402)
Inventories	(225,698)	(228,541)
Income taxes receivable	76,488	670
Prepayments and other	24,719	18,983
Increase (decrease) in current liabilities:
Accounts payable	109,912	298,916
Accrued liabilities	27,327	(7,888)
Turnaround expenditures	(32,236)	(170,468)
Other, net	3,662	34,804
Net cash provided by operating activities	805,933	802,163
Cash flows from investing activities:
Additions to properties, plants and equipment	(307,476)	(255,090)
Proceeds from sale of assets	14,711	5,802
Payments to Acquire Businesses, Net of Cash Acquired	0	11,301
Investment in Sabine Biofuels	(5,000)	(3,000)
Net repayment from (advances to) Sabine Biofuels	10,021	(11,040)
Purchases of marketable securities	(762,224)	(672,701)
Sales and maturities of marketable securities	863,769	646,301
Net cash used for investing activities	(247,856)	(332,128)
Cash flows from financing activities:
Early Repayment of Senior Debt	0	(300,973)
Repayments of Senior Debt	(156,188)
Proceeds from sale of HEP common units	0	73,444
Proceeds from common unit offerings - HEP	0	146,888
Purchase of treasury stock	(133,150)	(184,947)
Dividends	(485,766)	(485,411)
Excess tax benefit from equity based compensation	4,482	2,739
Deferred financing costs and other	(3,995)	668
Net cash used for financing activities	(642,154)	(933,250)
Cash and cash equivalents:
Increase for the period	(84,077)	(463,215)
Beginning of period	940,103	1,757,699
End of period	856,026	1,294,484
Cash paid during the period for:
Interest	45,672	67,822
Income taxes	222,488	336,588
HEP [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	45,739	48,410
Cash flows from investing activities:
Additions to properties, plants and equipment	(61,657)	(31,099)
Proceeds from sale of assets	0
Payments to Acquire Businesses, Net of Cash Acquired		11,301
Cash flows from financing activities:
Borrowings under credit agreement - HEP	538,600	256,500
Repayments under credit agreement - HEP	(346,600)	(312,500)
Repayments of Senior Debt	(156,188)	0
Proceeds from common unit offerings - HEP		73,444
Distributions to noncontrolling interest	(58,473)	(52,835)
Purchase of units for incentive grants - HEP	(1,064)	(3,379)
Deferred financing costs and other	0
Cash and cash equivalents:
Beginning of period	6,352
End of period	$ 1,667